Arena Pharmaceuticals (ARNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Sales | 53,562 | 19,242 | 9,512 | 9,847 | -17,177 |
| Cost of Goods | N/A | 2,812 | 2,609 | 3,616 | N/A |
| Gross Profit | 62,599 | 16,430 | 6,903 | 6,231 | -7,250 |
| Operating Expenses | 3,550 | 27,099 | 33,735 | 26,042 | 12,431 |
| Operating Income | 50,012 | -9,857 | -26,223 | -19,195 | -29,608 |
| Interest Expense | 1,605 | 1,609 | 1,619 | 1,679 | 1,695 |
| Other Income | 503 | -1,013 | 659 | -674 | -1,884 |
| Pre-tax Income | 48,910 | -12,479 | -27,183 | -21,548 | -33,187 |
| Net Income Continuous | 48,910 | -12,479 | -27,183 | -21,548 | -33,187 |
| Minority Interests | -258 | -122 | N/A | N/A | N/A |
| Net Income | $38,572 | $-12,357 | $-27,183 | $-21,548 | $-30,459 |
| EPS Basic Total Ops | 1.60 | -0.51 | -1.12 | -0.90 | -1.29 |
| EPS Basic Continuous Ops | 2.03 | -0.51 | -1.12 | -0.89 | -1.37 |
| EPS Diluted Total Ops | 1.60 | -0.51 | -1.12 | -0.90 | -1.29 |
| EPS Diluted Continuous Ops | 2.03 | -0.51 | -1.12 | -0.89 | -1.37 |
| EBITDA(a) | $47,931 | $-7,527 | $-23,799 | $-16,738 | $-31,692 |